Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for-composition-of-matter-patent-of-a-specific-polymorph-of-vidofludimus-calcium-in-the-united-states-302093964.html
https://www.prnewswire.com/news-releases/immunic-presents-data-from-phase-2-calliper-and-calvid-1-trials-of-vidofludimus-calcium-at-the-actrims-forum-2024-302073978.html
https://www.prnewswire.com/news-releases/immunic-inc-to-announce-financial-results-for-the-year-ended-december-31-2023-and-provide-corporate-update-302061844.html
https://www.prnewswire.com/news-releases/immunic-highlights-2023-accomplishments-and-upcoming-milestones-302027066.html
https://www.prnewswire.com/news-releases/immunic-inc-announces-private-placement-of-up-to-240-million-302027065.html
https://www.prnewswire.com/news-releases/immunic-to-announce-financial-results-for-the-third-quarter-ended-september-30-2023-and-provide-corporate-update-301979620.html
https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for-united-states-patent-protecting-the-treatment-of-relapsing-multiple-sclerosis-with-vidofludimus-and-its-salts-301975455.html
https://www.prnewswire.com/news-releases/immunic-to-participate-in-scientific-and-industry-conferences-in-november-301968303.html
https://www.prnewswire.com/news-releases/immunic-presents-data-from-phase-2-caldose-1-trial-of-vidofludimus-calcium-in-ulcerative-colitis-at-the-united-european-gastroenterology-week-2023-301956189.html
https://www.prnewswire.com/news-releases/immunic-presents-data-from-phase-1b-clinical-trial-of-imu-856-in-celiac-disease-at-the-united-european-gastroenterology-week-2023-301956187.html